Parathyroid hormone synthesis, secretion and action
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05B ANTI-PARATHYROID AGENTS
H05BX Other anti-parathyroid agents
H05BX04 Etelcalcetide
D10677 Etelcalcetide hydrochloride (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Metabolic Bone Disease Agents
Calcium-sensing Receptor Agonist
Etelcalcetide
D10677 Etelcalcetide hydrochloride (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D10677 Etelcalcetide hydrochloride (JAN/USAN); Velcalcetide hydrochloride (USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Metabotropic glutamate receptor family
Calcium-sensing
CASR
D10677 Etelcalcetide hydrochloride (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10677
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10677
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10677
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10677